Balaji et al. evaluated neurodevelopment in children with/at-risk of severe spinal muscular atrophy type 1, highlighting diverse outcomes influenced by survival motor neuron 2 (SMN2) copies, diagnostic modality, and parental well-being, within a bioecological model. The gene discussed is SMN2; the disease is spinal muscular atrophy, type 1.